Zevra Therapeutics (ZVRA) announces CFO Resignation

On November 20, 2025, R. LaDuane Clifton, the Chief Financial Officer and Treasurer and principal financial officer of Zevra Therapeutics (NASDAQ: ZVRA) notified the Company of his decision to resign from his position, effective December 31, 2025 (the “Separation Date”), in order to pursue other professional opportunities.

You May Also Be Interested In

• Quantum Cyber names Tzvi Lev as head of Middle East sales
• Cronos expands Spinach cannabis edibles and vape lineup in Canada
• FDA accepts United Therapeutics' sNDA for Tyvaso to treat IPF